A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection
Clinical trial NCT05242445 · COMPLETED
Trial details
- NCT number
- NCT05242445
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2023-05-09
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.